| http://www.w3.org/ns/prov#value | - Such diversity constitutes a real challenge to the immune responses developed by the host to fight against such pathogens as well as impedes the development of an effective vaccine or new treatments.At present, no vaccine has been developed for HCV and current treatment, which consists of a combination of pegylated interferon alpha and ribavirin, remains expensive, has serious side effects, and is
|